Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $24 to $21.
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and lowers the price target from $24 to $21.